Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system.

Egan GM, Siskin GP, Weinmann R 4th, Galloway MM.

J Infus Nurs. 2013 May-Jun;36(3):181-8. doi: 10.1097/NAN.0b013e3182893690.

PMID:
23558917
2.

Molecular biomarkers in glaucoma.

Bhattacharya SK, Lee RK, Grus FH; Seventh ARVO/Pfizer Ophthalmics Research Institute Conference Working Group.

Invest Ophthalmol Vis Sci. 2013 Jan 7;54(1):121-31. doi: 10.1167/iovs.12-11067. No abstract available.

3.

Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.

Lu KV, Zhu S, Cvrljevic A, Huang TT, Sarkaria S, Ahkavan D, Dang J, Dinca EB, Plaisier SB, Oderberg I, Lee Y, Chen Z, Caldwell JS, Xie Y, Loo JA, Seligson D, Chakravari A, Lee FY, Weinmann R, Cloughesy TF, Nelson SF, Bergers G, Graeber T, Furnari FB, James CD, Cavenee WK, Johns TG, Mischel PS.

Cancer Res. 2009 Sep 1;69(17):6889-98. doi: 10.1158/0008-5472.CAN-09-0347. Epub 2009 Aug 18.

4.

BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors.

Copland M, Pellicano F, Richmond L, Allan EK, Hamilton A, Lee FY, Weinmann R, Holyoake TL.

Blood. 2008 Mar 1;111(5):2843-53. Epub 2007 Dec 21. Erratum in: Blood. 2008 May 1;111(9):4830.

5.

Jack Ruby.

Weinmann RL.

Neurology. 2007 Aug 28;69(9):940-1; author reply 941. No abstract available.

PMID:
17724305
6.

Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.

Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY, Li S.

Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16870-5. Epub 2006 Oct 31.

7.

California's prison health system.

Weinmann RL.

Lancet. 2005 Nov 12;366(9498):1691. No abstract available.

PMID:
16291054
8.

Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3).

Spires TE, Fink BE, Kick EK, You D, Rizzo CA, Takenaka I, Lawrence RM, Ruan Z, Salvati ME, Vite GD, Weinmann R, Attar RM, Gottardis MM, Lorenzi MV.

Prostate. 2005 Oct 1;65(2):159-70.

PMID:
15924334
9.

Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus.

Salvati ME, Balog A, Wei DD, Pickering D, Attar RM, Geng J, Rizzo CA, Hunt JT, Gottardis MM, Weinmann R, Martinez R.

Bioorg Med Chem Lett. 2005 Jan 17;15(2):389-93.

PMID:
15603960
10.

Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists.

Salvati ME, Balog A, Shan W, Wei DD, Pickering D, Attar RM, Geng J, Rizzo CA, Gottardis MM, Weinmann R, Krystek SR, Sack J, An Y, Kish K.

Bioorg Med Chem Lett. 2005 Jan 17;15(2):271-6.

PMID:
15603938
11.

The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.

Balog A, Salvati ME, Shan W, Mathur A, Leith LW, Wei DD, Attar RM, Geng J, Rizzo CA, Wang C, Krystek SR, Tokarski JS, Hunt JT, Gottardis M, Weinmann R.

Bioorg Med Chem Lett. 2004 Dec 20;14(24):6107-11.

PMID:
15546739
12.

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.

Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR Jr, Weinmann R, Einspahr HM.

Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4904-9.

13.
14.

Transforming region of 243R E1A contains two overlapping but distinct transactivation domains.

Sang N, Claudio PP, Fu Y, Horikoshi N, Graeven U, Weinmann R, Giordano A.

DNA Cell Biol. 1997 Nov;16(11):1321-33.

PMID:
9407004
15.

Medical red-lining: economic credentials for physicians.

Weinmann RL.

Clin Electroencephalogr. 1996 Oct;27(4):VI-VII. No abstract available.

PMID:
9465279
16.

Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex.

Kashanchi F, Khleif SN, Duvall JF, Sadaie MR, Radonovich MF, Cho M, Martin MA, Chen SY, Weinmann R, Brady JN.

J Virol. 1996 Aug;70(8):5503-10.

17.

Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

Carboni JM, Yan N, Cox AD, Bustelo X, Graham SM, Lynch MJ, Weinmann R, Seizinger BR, Der CJ, Barbacid M, et al.

Oncogene. 1995 May 18;10(10):1905-13.

PMID:
7761092
18.

Adenovirus E1A proteins interact with the cellular YY1 transcription factor.

Lewis BA, Tullis G, Seto E, Horikoshi N, Weinmann R, Shenk T.

J Virol. 1995 Mar;69(3):1628-36.

19.
20.

Managed care: the dark side.

Weinmann RL.

Clin Electroencephalogr. 1994 Apr;25(2):VI-VII. No abstract available.

PMID:
8194186

Supplemental Content

Loading ...
Support Center